Marco Montagna

Istituto Oncologico Veneto

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Biostatistics

100%

Epidemiology

100%

Cancer Biology

90%

Genome-wide Association

70%

Medical Science

60%

Gwas

50%

Polycystic Ovary Syndrome

50%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles14

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.

Article Link

Year:

2023

ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.

Article Link

Year:

2023

Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study.

Article Link

Year:

2023

Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

Article Link

Year:

2022

Polygenic risk modeling for prediction of epithelial ovarian cancer risk

Article Link

Year:

2022

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

Article Link

Year:

2022

Polygenic risk modeling for prediction of epithelial ovarian cancer risk (vol 30, pg 349, 2021)

Article Link

Year:

2022

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Article Link

Year:

2021

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Article Link

Year:

2021

The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

Article Link

Year:

2021

Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

Article Link

Year:

2020

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

Article Link

Year:

2020

Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Article Link

Year:

2020

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Article Link

Year:

2020

Collaborators29

Weiva Sieh

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

Francine Durocher

Professeure titulaire

Laval University

CANADA

Kathleen Claes

Associate professor

Ghent University Hospital

BELGIUM

Greet Wieme

Ghent University Hospital

BELGIUM

Adalgeir Arason

ICELAND

Niclas Håkansson

Karolinska Institutet

SWEDEN

Katherine Nathanson

Professor

University of Pennsylvania

UNITED STATES

Jacques Simard

Full Professor

Laval University

CANADA

Uffe Birk Jensen

Aarhus University

DENMARK

Emmanouil Saloustros

Associate Professor

Panepistemio Thessalias Tmema Iatrikes

GREECE

Alexandra Martins

INSERM

FRANCE

Giuseppe Damante

ITALY

Claus Høgdall

Professor in Clinical Gynecologic Oncology

University of Copenhagen

DENMARK

Diana M Eccles

University of Southampton

UNITED KINGDOM

Juliet French

Program Director/Laboratory Head

QIMR Berghofer Medical Research Institute

AUSTRALIA

Mariarosaria Calvello

European Institute of Oncology

ITALY

Allison DePersia

NorthShore University HealthSystem

UNITED STATES

Taru Muranen

University of Helsinki

FINLAND

Angela Brooks-Wilson

Simon Fraser University

CANADA

Marketa Janatova

Assistanf Professor and researcher

Přírodovědecká Fakulta, Univerzita Karlova

CZECH REPUBLIC

Anna Gonzalez-Neira

Head

Centro Nacional de Investigaciones Oncológicas

SPAIN

Daehee Kang

Professor

Seoul National University

SOUTH KOREA

Eileen Dareng

University of Cambridge

UNITED KINGDOM

Eunjung Lee

Assistant Professor of Research

UNITED STATES

Manuel António Rodrigues Teixeira

Guest Full Professor

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar

PORTUGAL

Alvaro Monteiro

Senior Member - Full Professor

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES

Lidia Feliubadaló

SPAIN

Susan Ramus

Professor of Molecular Oncology

University of New South Wales

AUSTRALIA

Zdenek Kleibl

CZECH REPUBLIC

How do I reach out?

Meet Kite AI